Name: Latest research reports of Alembic Pharmaceuticals Ltd. authored by KRChoksey and published by - Trendlyne research reports.
Item: Alembic Pharmaceuticals Ltd.
Rating: 3
Author: KRChoksey

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	08 Nov 2024	Alembic Pharma	KRChoksey Target	981.40	1087.00	1038.20 (-5.47%)	Target met	Hold	pdf post cache	Broker Report New launches in US and market share gains in Ex-USA will drive growth KRChoksey Alembic Pharma’s revenue missed our estimate (-4.8%) due to decline in API segment and moderate growth in India and US. However, EBITDA was in-line and Adj. PAT was largely in-line (+2.5%) with our estimate. pdf Copy Link Share on Share on Share on Share on Alert
	08 Nov 2024	Mold-Tek Packaging	Axis Direct Reco Target	672.45	785.00	702.00 (-4.21%)	16.74	Hold	pdf post cache	Broker Report Result Update:Mold-Tek Pack. Axis Direct We have revised our rating on the stock from BUY to HOLD as volume and margin recovery is now expected in FY26E and onwards. pdf Copy Link Share on Share on Share on Share on Alert
	08 Nov 2024	Page Industries	Axis Direct Target	46345.00	44500.00	48002.90 (-3.45%)	Target met	Hold	pdf post cache	Broker Report Result Update:Page Industries Axis Direct With a 1% downside from the CMP, we maintain our HOLD rating on the stock. pdf Copy Link Share on Share on Share on Share on Alert
	08 Nov 2024	Endurance Tech	Axis Direct Target	2453.90	2520.00	2426.70 (1.12%)	Target met	Hold	pdf post cache	Broker Report Result Update:Endurance Tech. Axis Direct We maintain our HOLD rating on the stock. pdf Copy Link Share on Share on Share on Share on Alert
	08 Nov 2024	Escorts Kubota	Axis Direct Target	3249.20	3290.00	3635.50 (-10.63%)	Target met	Hold	pdf post cache	Broker Report Result Update:Escorts Kubota Axis Direct We maintain our HOLD rating on the stock pdf Copy Link Share on Share on Share on Share on Alert
	08 Nov 2024	Astral	Axis Direct Target	1522.40	1800.00	1788.80 (-14.89%)	Target met	Hold	pdf post cache	Broker Report Result Update:Astral Axis Direct Continuous EBITDA deterioration due to low PVC Prices, and higher PEx multiples are not sustainable. Therefore, we retain our HOLD rating with TP Rs 1,800/share. pdf Copy Link Share on Share on Share on Share on Alert
	08 Nov 2024	Escorts Kubota	Motilal Oswal Target	3249.20	3560.00	3635.50 (-10.63%)	Target met	Neutral	pdf post cache	Broker Report Tractor demand set to revive from H2 Motilal Oswal Escorts Kubota’s (ESCORTS) 2QFY25 operating performance was stable YoY as the company reported flattish revenue/EBITDA growth YoY. pdf Copy Link Share on Share on Share on Share on Alert
	08 Nov 2024	Apollo Hospitals	ICICI Direct Target	6855.00	7260.00	7421.40 (-7.63%)	Target met	Hold	pdf post cache	Broker Report Apollo Hospitals ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	08 Nov 2024	Astral	IDBI Capital Target	1522.40	1943.00	1788.80 (-14.89%)	27.63	Hold	pdf post cache	Broker Report Astral: Q2FY25 Result Review IDBI Capital pdf Copy Link Share on Share on Share on Share on Alert
	08 Nov 2024	Clean Science	IDBI Capital	1489.30	1500.00	1479.75 (0.65%)	Target met	Hold	pdf post cache	Broker Report Clean Science and Technology: Q2FY25 Result Review IDBI Capital pdf Copy Link Share on Share on Share on Share on Alert
more loading

Neutral

Latest broker research reports with buy, hold and sell recommendations along with share price targets forecast and upside. Browse thousands of reports and search by company or broker.

Broker Research reports: All reports

New launches in US and market share gains in Ex-USA will drive growth

Result Update:Mold-Tek Pack.

Result Update:Page Industries

Result Update:Endurance Tech.

Result Update:Escorts Kubota

Result Update:Astral

Tractor demand set to revive from H2

Apollo Hospitals

Astral: Q2FY25 Result Review

Clean Science and Technology: Q2FY25 Result Review

Advisor Screeners